Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-13-015384)

Filing Details

Accession Number:: 0001127602-13-015384
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-05-03 10:52:42
Reporting Period:: 2013-05-01

Filing Date:: 2013-05-03
Accepted Time:: 2013-05-03 10:52:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
794172	Meridian Bioscience Inc	VIVO	In Vitro & In Vivo Diagnostic Substances (2835)	310888197

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1224662	A John Kraeutler	3471 River Hills Drive Cincinnati OH 45244	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-05-01	5,000	$19.63	225,718	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	638	Indirect	Held in Meridian Savings & Investment Plan (401K)

Footnotes

Prices range from $19.5900 per share to $19.6400 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.